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Rupture of intracranial aneurysms (IAs) causes subarachnoid hemorrhage, a devastating condition with high mor-
bidity and mortality. Angiographic and autopsy studies show that IA is a common disorder, with a prevalence of
3%–6%. Although IA has a substantial genetic component, little attention has been given to the genetic determinants.
We report here a genomewide linkage study of IA in 104 Japanese affected sib pairs in which positive evidence of
linkage on chromosomes 5q22-31 (maximum LOD score [MLS] 2.24), 7q11 (MLS 3.22), and 14q22 (MLS 2.31)
were found. The best evidence of linkage is detected at D7S2472, in the vicinity of the elastin gene (ELN), a
candidate gene for IA. Fourteen distinct single-nucleotide polymorphisms (SNPs) were identified in ELN, and no
obvious allelic association between IA and each SNP was observed. The haplotype between the intron-20/intron-
23 polymorphism of ELN is strongly associated with IA ( ), and homozygous patients are at high56Pp 3.81 # 10
risk ( ), with an odds ratio of 4.39. These findings suggest that a genetic locus for IA lies within or closePp .002
to the ELN locus on chromosome 7.
Introduction
Large autopsy studies reveal that intracranial aneurysms
(IAs [MIM 105800]) have a prevalence of 4.6% (Iwamoto
et al. 1999), and angiographic studies indicate the prev-
alence of unruptured incidental IA among adults to be
2.7%–6.5% (Ujiie et al. 1993; Nakagawa and Hashi
1994). Rupture of an IA causes sudden subarachnoid
hemorrhage (SAH), with high morbidity and mortality.
For all ages, the annual incidence of SAH due to aneu-
rysmal rupture is 18–23/100,000 (Inagawa et al. 1988,
1995); for individuals 40 years old, it is 96/100,000
(Kiyohara et al. 1989). For patients with SAH, 8%–12%
die before receiving medical attention (Phillips et al. 1980;
Inagawa et al. 1995; Schievink et al. 1995b), 40%–60%
die 1 mo after onset of the disease (Sacco et al. 1984;
Kiyohara et al. 1989; Inagawa et al. 1995), and more
than a third of those who survive show major neurological
deficits (Longstreth et al. 1993; Inagawa et al. 1995).
Despite the improvements in medical and surgical care
and in diagnostic methods during the past decades, aneu-
rysmal SAH is still a major public health problem.
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Although genetic and environmental factors play
equally important roles in the etiology of IA, recent pro-
gress in molecular genetics enables us to approach the
genetic determinants directly. The risk of ruptured IA in
first-degree relatives of patients with aneurysmal SAH is
four times higher, and the relative risk in siblings is six
times higher, than that in the general population (Schie-
vink et al. 1995a; Ronkainen et al. 1997). A small frac-
tion of IA is associated with heritable connective-tissue
diseases such as polycystic kidney disease, Ehlers-Danlos
syndrome type IV, and Marfan syndrome (Schievink
1997). Segregation analysis has been unable to define the
inheritance pattern of IA (Schievink et al. 1994), possibly
because of the complex etiology of the disease. We per-
formed a genetic linkage study with Japanese nuclear
families, to identify susceptible loci underlying IA, es-
pecially ruptured IA. Because IA has late onset and low
penetrance, an occult phenotype may exist in a family,
and complicated etiologies frequently are involved, so
only affected sib pairs (ASPs) were used for the nonpara-
metric linkage study. Difficulties in collection of ASPs
were expected, because of the high mortality in ruptured
IA. At all 1,100 hospitals in Japan that have been certified
as training hospitals by the Japan Neurosurgical Society,
we inquired regarding ASPs with IA. We were able to
enroll 104 ASPs, comprising mainly patients with rup-
tured IA, at 94 of these hospitals. The subjects were ex-
amined in a genomewide linkage study. The best evidence
of linkage was obtained on chromosome 7, near marker
D7S2472, and the elastin gene (ELN), encoding a major
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Table 1
Samples Used for Affected Sib Pair Linkage Analysis
FAMILY
STRUCTURE
NO. OF
Families
Individuals Sib Pairs
SAH
Positive
SAH
Negative Total
Pairs 68 9 77 154 77
Trios 4 3 7 21 21
Quartets 1 0 1 4 6
Total 73 12 85 179 104
component of the blood-vessel wall, was found to lie very
close to the marker. Since ELN is both a positional and
functional candidate gene for IA, it was analyzed for
allelic association, haplotype association, and linkage dis-
equilibrium (LD).
Subjects and Methods
Subjects
Current samples comprise 85 nuclear families col-
lected through neurosurgical services certified by the Ja-
pan Neurosurgical Society, and the number of possible
ASPs was 104. The Ethical Committee of the Tokyo
Women’s Medical University approved the study, and all
the participants (or their family members) gave written,
informed consent. The families included at least two af-
fected siblings, each of whom had an IA 15 mm, as
ascertained by conventional angiography, three-dimen-
sional computed tomography (CT) angiography, mag-
netic resonance (MR) angiography, or surgical findings.
This collected sample comprised 179 individuals—51
males and 128 females. ASPs comprised 77 pairs, 7 trios,
and 1 quartet of siblings with IA. In the 77 pairs, SAH
(i.e., ruptured IA) was present in both siblings in 41
pairs, in one sibling in 27 pairs, and in neither sibling
in 9 pairs; in the 7 trios, SAH was present in all three
siblings in 3 trios, one sibling in 1 trio, and in none of
the siblings in 3 trios; in the quartet, SAH was present
in only one individual. Of the 85 families, 73 had at
least one member with SAH (table 1). The detailed clin-
ical features of these families have been reported else-
where (Kasuya et al. 2000).
For the allelic-ssociation study, 172 patients with IA
(70 men and 102 women; mean [SD] age 59.8 [10.5]
years) and 192 controls (91 men and 101 women; mean
[SD] age 59.0 [16.5] years) were enrolled. All subjects
were of Japanese ethnicity. The 172 patients with IA in-
clude 78 probands in nuclear families, 9 patients with
first-degree relatives with IA, and 85 patients without
known family history of IA. The 192 controls were out-
patients of Tokyo Women’s Medical University Hospital
who presented with headache and other neurological
complaints. Selected controls had no history of SAH and
were of ages similar to those of the patients with IA and,
on conventional CT examination, showed no evidence of
IA.
Genotyping
PCR amplifications were performed on the basis of
standard protocols. Genotyping was performed, by a
fluorescence-based semiautomated technique, on a DNA
Sequencer model 377 (Applied Biosystems), with Link-
age Mapping Set version 2 (Applied Biosystems). The
marker alleles were assigned by GENESCAN and GE-
NOTYPER software (Applied Biosystems). Heterozy-
gosity of each microsatellite marker was determined on
the basis of 64 unrelated healthy Japanese from various
regions in Japan. Of the 400 markers in the set, 43 were
not informative; the other 357, which, in 64 unrelated
Japanese healthy subjects, had heterozygosities 160%,
were analyzed. A set of 47 markers obtained from online
information was added to the original set, to fill in gaps
120 cM (primer sequences of these additional markers
are available on request). The average heterozygosity of
the total of 404 markers was .756 in Japanese. The av-
erage interval between markers was 8.7 cM, and two
gaps were 120 cM (maximum 26.8 cM).
Linkage Analysis
Because the mode of inheritance of IA is not known,
we applied two different nonparametric linkage meth-
ods—the SIBPAL program from the S.A.G.E. package
(version 3.1) (Elston et al. 1997) and the GENEHUNTER
program (version 1.2) (Kruglyak et al. 1996). The SIBPAL
program estimated the mean ratio (p) of alleles shared
identical by descent (IBD) among ASPs, at each micro-
satellite marker. The p obtained was tested against the
null hypothesis of no linkage ( ). The test statisticpp .5
has a standard normal distribution under the null hy-
pothesis, and, because the alternative hypothesis of link-
age is given when IBD sharing is 150%, the test is one
sided. Accordingly, accurate p values can be obtained by
use of a one sided p-test as implemented in the SIBPAL
program. Multipoint linkage analysis was performed by
a maximum-likelihood method implemented in the
GENEHUNTER program. Maximum LOD score (MLS)
was calculated by the method of possible triangle con-
straints (Kruglyak et al. 1996). All sib pairs from sibships
containing more than two affected individuals were
counted, and the unweighted option was used.
Physical Map of the ELN Locus
A physical map of the ELN locus was constructed
on the basis of both the GenBank database (accession
numbers AC005089, AC005056, U93037, U63721,
U62292, U62293, AC005057, AF045555, AC005081,
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Figure 1 Radiographic examinations for IA. A 51-year-old male patient with a complaint of vertigo received MR imaging, which showed
a flow void, an indication of aneurysm, in the left middle cerebral artery (a, arrow). Cerebral angiography (b, arrow) and three-dimensional
CT angiography (c, arrow) further confirmed IA.
and AC005015.2) and the physical map of the micro-
deletion in Williams-Beuren syndrome (WBS) (Peoples
et al. 2000). Eight polymorphic dinucleotide or tetra-
nucleotide repeats in the vicinity were discovered, and
linkage and allelic association studies were performed.
Single-Nucleotide Polymorphisms (SNPs) of ELN
A total of 16 IA probands and 8 controls were
screened to identify SNPs of ELN. Direct sequencing
was performed on PCR-amplified segments spanning all
34 exons, acceptor, donor, and branch-point sequences
in the introns, 1.0 kb of putative promoter sequence,
and 1.2 kb of the 3′UTR sequence. A total of 42 primer
sets were designed on the basis of the humanELN cDNA
and genomic sequences (accession numbers M36860 and
AC005056, respectively), obtained from the GenBank
database. Primer sequences and PCR conditions are
available from the authors on request.
Allelic Association, Haplotype Analysis, and LD
Allelic association with IA was evaluated by x2 test
statistic, for each SNP; the odds ratio and 95% confidence
interval (95%CI) also were calculated for each SNP. Be-
cause the gametic phase was unknown, the haplotype
frequencies were calculated from two-locus genotype data
by the maximum-likelihood estimates, by use of the AR-
LEQUIN program. The haplotype frequencies of ELN
were compared in patients with IA versus controls and
were evaluated by the contingency table of x2 test statis-
tics. The extent of pairwise LD (D) was evaluated as
, where p11, p22, p12, and p21 are theDp p p  p p11 22 12 21
frequencies of haplotypes of A1B1, A2B2, A1B2, and A2B1,
respectively, at loci A and B. p1, p2, q1, and q2 are the
frequencies of alleles A1, A2, B1, and B2, respectively and
two LD measures are applied: first, coefficient D′ is given
by D/Dmax, where either Dmax is the smaller of p1q2 and
p2q1 when or Dmax is the smaller of p1q1 and p2q2D 1 0
when (Lewontin 1964); second, r2 is given by D2/D ! 0
(p1p2q1q2) (Hill and Robertson 1968).
Results
Radiographic Examinations of IA
Modern diagnostic techniques allow the detection of
many potentially dangerous conditions before symptoms
occur. Most patients with IA are asymptomatic, how-
ever, until sudden rupture and life-threatening SAH. IA
could be diagnosed by various radiographic methods,
such as cerebral angiography, three-dimensional CT an-
giography, and MR angiography. Figure 1 shows MR
Table 2
Single-Point Linkage Analysis by SIBPAL
Chromosome and Marker
Distance
(cM) Heterozygosity No. of Pairs IBD t P
1:
D1S468 6.2 .71 83 .52 .73 .234
D1S214 16.4 .72 83 .51 .47 .320
D1S450 22.9 .85 81 .49 .41 .659
D1S2667 26.9 .82 82 .47 .9 .815
D1S507 36.2 .83 80 .44 2.07 .979
D1S199 47.7 .77 83 .48 .6 .726
D1S234 56.6 .81 81 .49 .35 .638
D1S496 65.6 .87 70 .48 .54 .706
D1S2797 77.6 .78 83 .55 1.81 .037*
D1S2700 89.3 .83 82 .52 .51 .304
D1S230 97.4 .61 83 .49 .3 .619
D1S2841 108.8 .83 83 .50 .11 .456
D1S207 117.6 .83 81 .49 .31 .622
D1S2868 129.9 .61 80 .55 2.05 .022*
D1S206 137.6 .78 83 .45 1.88 .968
D1S2726 149 .72 83 .49 .28 .612
D1S252 155.1 .80 82 .50 .01 .496
D1S498 160.7 .73 82 .51 .21 .418
D1S484 173.9 .68 82 .47 1.08 .859
D1S2878 181.7 .84 83 .47 .84 .798
D1S196 186.4 .72 83 .53 1.22 .114
D1S218 196.5 .82 83 .50 .13 .553
D1S238 206.7 .81 82 .52 .6 .274
D1S413 216.5 .63 82 .50 .12 .453
D1S249 225.1 .67 83 .52 .54 .296
D1S425 235.3 .61 82 .51 .49 .314
D1S213 246.2 .85 81 .50 .04 .483
D1S2800 256.1 .71 83 .50 .12 .452
D1S2785 269.7 .85 82 .50 .11 .542
D1S2842 277.3 .72 81 .47 .93 .822
D1S2836 290.1 .68 83 .44 1.98 .975
2:
D2S319 6 .72 82 .47 1.00 .839
D2S2211 14 .64 83 .51 .33 .371
D2S162 21.3 .79 83 .48 .69 .755
D2S168 28.6 .80 82 .49 .43 .664
D2S305 40.7 .77 81 .51 .37 .358
D2S165 50.7 .86 81 .46 1.02 .845
D2S367 58.3 .87 83 .50 .15 .558
D2S2259 67.4 .62 83 .49 .25 .598
D2S391 73.8 .71 82 .48 .59 .720
D2S337 84.1 .84 82 .43 2.24 .986
D2S2368 89.2 .83 83 .44 2.22 .986
D2S286 98.4 .74 81 .47 .86 .803
D2S2333 107.7 .84 83 .52 .77 .223
D2S2216 115.3 .72 82 .48 .84 .799
D2S160 127.4 .71 83 .54 1.73 .044*
D2S347 135.7 .61 81 .45 1.8 .962
D2S112 145.8 .60 83 .47 1.18 .880
D2S151 156.4 .77 82 .44 2.29 .988
D2S142 166.3 .73 82 .44 2.08 .980
D2S2330 175.5 .84 83 .49 .20 .580
D2S335 182.5 .84 83 .49 .30 .617
D2S364 192.9 .78 82 .45 1.66 .949
D2S117 201.4 .88 83 .47 .79 .784
D2S325 210.9 .79 82 .45 1.67 .951
D2S164 222 .65 80 .45 1.85 .966
D2S126 228.8 .80 82 .48 .60 .725
D2S396 240.2 .85 82 .50 .16 .562
D2S206 248.3 .80 82 .54 1.35 .091
D2S338 258.7 .81 83 .51 .38 .353
D2S125 269.5 .81 83 .52 .74 .232
3:
D3S1297 2.5 .76 83 .54 1.47 .073
D3S1304 16.5 .79 82 .50 .17 .569
D3S1263 30.4 .89 83 .47 1.08 .858
D3S2338 36.3 .73 82 .48 .63 .736
D3S1266 46.9 .66 83 .48 .85 .801
D3S1277 56.1 .69 80 .47 1.22 .887
D3S1289 69.1 .81 81 .48 .49 .686
D3S1300 79 .81 80 .55 1.42 .080
D3S1285 91 .76 83 .48 .61 .728
D3S1566 97.2 .84 80 .46 1.26 .895
D3S3681 108.8 .82 79 .52 .73 .235
D3S1271 117.7 .60 83 .53 1.42 .080
D3S1278 131.8 .70 83 .51 .33 .373
D3S1267 141.1 .65 83 .47 1.08 .859
D3S1292 148.7 .89 83 .51 .42 .338
D3S1569 162 .79 83 .45 1.84 .965
D3S1279 173 .62 83 .45 1.98 .975
D3S1614 183.1 .67 83 .54 1.63 .053
D3S1565 193 .80 83 .52 .66 .257
D3S1262 207.2 .72 83 .52 .65 .259
D3S1580 213.7 .84 82 .53 .95 .172
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Table 2 (Continued)
Chromosome and Marker
Distance
(cM) Heterozygosity No. of Pairs IBD t P
D3S1601 220.4 .79 83 .53 1.04 .150
D3S1311 230.7 .73 82 .55 2.22 .014*
4:
D4S412 3.7 .68 83 .47 .94 .824
D4S2935 12.2 .64 82 .50 .06 .476
D4S3036 23.1 .78 82 .50 .09 .534
D4S419 32.6 .69 83 .53 1.11 .134
D4S391 43.2 .78 83 .53 1.23 .112
D4S405 56.7 .75 83 .49 .21 .582
D4S1592 68.4 .78 83 .50 .15 .558
D4S392 77.9 .82 82 .54 1.16 .125
D4S2964 87.1 .70 83 .50 .16 .565
D4S1534 93.5 .80 83 .52 .56 .287
D4S414 99.2 .75 83 .52 .62 .268
D4S1572 106.3 .83 83 .52 .72 .236
D4S406 115.8 .70 81 .51 .31 .379
D4S402 123.5 .84 81 .54 1.16 .124
D4S3039 131.9 .82 81 .53 .89 .189
D4S424 143.8 .76 83 .52 .69 .247
D4S413 157.9 .62 83 .54 1.57 .060
D4S2979 170.9 .65 81 .50 .17 .567
D4S2991 179.6 .81 82 .55 1.77 .040*
D4S415 185 .73 82 .52 .62 .269
D4S1535 198.5 .76 81 .52 .85 .198
D4S426 211 .72 83 .48 .62 .733
5:
D5S1981 .6 .76 83 .51 .47 .321
D5S406 10.7 .73 82 .51 .43 .333
D5S630 18.6 .90 83 .52 .46 .322
D5S416 27.9 .64 81 .50 .07 .473
D5S419 39.5 .87 80 .47 1.02 .846
D5S426 51.6 .78 82 .48 .75 .772
D5S418 58.1 .78 81 .54 1.19 .12
D5S407 65 .86 83 .52 .48 .316
D5S647 74.7 .82 83 .54 1.25 .108
D5S424 82.8 .68 82 .52 .86 .196
D5S641 92.3 .81 82 .51 .33 .371
D5S428 95.4 .68 81 .57 3.09 .001**
D5S644 104.5 .83 81 .56 2.14 .018*
D5S433 112.2 .75 83 .53 1.08 .141
D5S2027 118.9 .59 82 .52 .79 .216
D5S471 129.6 .71 83 .53 1.40 .083
D5S2115 138.6 .74 82 .54 1.45 .075
D5S436 147.2 .75 83 .52 .74 .231
D5S410 156 .57 83 .50 .01 .496
D5S422 163.9 .81 82 .50 .11 .545
D5S400 174.3 .88 82 .50 .01 .496
D5S1960 179.1 .73 64 .48 .59 .721
D5S408 195.8 .68 81 .49 .24 .596
6:
D6S1574 8.7 .73 81 .50 .12 .549
D6S309 13.6 .76 80 .52 .84 .200
D6S470 17.7 .72 82 .47 1.08 .859
D6S289 29.6 .81 83 .50 .11 .458
D6S422 35.7 .67 83 .52 .77 .223
D6S276 44.9 .73 83 .53 1.05 .148
D6S1610 53.9 .78 83 .51 .42 .339
D6S1575 60.7 .84 83 .54 1.32 .095
D6S452 72.2 .85 80 .47 1.01 .843
D6S257 80 .88 83 .51 .30 .384
D6S460 90 .80 82 .50 .09 .462
D6S300 103.5 .71 82 .53 .96 .170
D6S434 109.2 .78 83 .53 1.00 .161
D6S287 122 .68 81 .51 .55 .291
D6S262 129.8 .77 83 .52 .48 .317
D6S292 138.2 .85 82 .49 .25 .599
D6S308 145.5 .65 83 .50 .14 .444
D6S441 155.3 .79 81 .50 .08 .469
D6S305 166.6 .82 80 .48 .47 .682
D6S1719 177.9 .77 79 .47 .89 .812
D6S281 201.1 .81 83 .46 1.18 .880
7:
D7S531 4.8 .77 81 .53 1.14 .130
D7S517 7.8 .79 83 .54 1.55 .063
D7S513 17.7 .9 83 .53 .89 .189
D7S507 29.1 .82 83 .50 .09 .538
D7S493 35 .73 83 .49 .29 .615
D7S516 42.1 .76 83 .49 .24 .596
D7S484 55.6 .79 82 .51 .34 .367
D7S510 60.5 .82 83 .55 1.87 .032*
D7S519 70.5 .74 83 .53 1.32 .095
D7S502 79.6 .85 82 .54 1.13 .131
D7S669 90.9 .83 83 .56 2.06 .021*
D7S630 98.7 .77 82 .55 1.77 .040*
D7S657 105.2 .77 83 .54 1.52 .066
D7S515 112.9 .75 83 .56 2.24 .014*
D7S486 125.3 .76 83 .50 .05 .478
D7S530 136.4 .72 81 .48 .59 .722
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Table 2 (Continued)
Chromosome and Marker
Distance
(cM) Heterozygosity No. of Pairs IBD t P
D7S640 139.7 .85 83 .48 .59 .722
D7S684 149.6 .78 83 .45 1.68 .952
D7S661 157.5 .84 83 .47 .95 .828
D7S636 165 .93 82 .47 .70 .757
D7S798 171.3 .75 80 .52 .62 .270
D7S2465 182.1 .77 81 .53 .83 .204
8:
D8S264 .7 .83 83 .52 .65 .260
D8S277 8.4 .81 80 .48 .58 .717
D8S550 20.4 .72 83 .48 .62 .731
D8S1731 30.7 .70 82 .49 .20 .581
D8S258 40.3 .68 83 .51 .51 .304
D8S177 1 49.6 .68 80 .45 1.70 .953
D8S505 60 .77 83 .46 1.31 .904
D8S285 70.6 .70 83 .46 1.31 .904
D8S260 78.8 .76 83 .50 .04 .482
D8S543 86.7 .73 80 .52 .93 .177
D8S1705 94.3 .75 83 .55 1.60 .057
D8S270 102.1 .70 82 .52 .87 .194
D8S514 128.9 .77 83 .50 .18 .428
D8S284 142.7 .80 81 .51 .17 .432
D8S272 152.5 .80 83 .50 .06 .525
9:
D9S288 8.8 .81 83 .57 2.34 .011*
D9S286 16.8 .75 81 .53 1.13 .131
D9S285 27.9 .62 83 .49 .39 .650
D9S157 31.8 .83 83 .52 .50 .309
D9S265 42 .63 83 .53 1.35 .090
D9S1678 50.3 .75 79 .51 .34 .368
D9S1817 57.9 .86 83 .51 .47 .320
D9S166 65 .75 82 .53 1.19 .118
D9S175 68.8 .62 82 .50 .13 .447
D9S167 82.4 .84 83 .55 1.50 .069
D9S283 93.2 .73 81 .51 .42 .338
D9S287 103.3 .64 82 .52 .99 .162
D9S1690 106.5 .78 83 .52 .58 .281
D9S1677 117.8 .87 82 .53 1.00 .160
D9S1776 124.2 .76 83 .51 .22 .413
D9S1682 132.9 .64 78 .51 .52 .301
D9S290 141.1 .66 83 .46 1.44 .923
D9S164 148.1 .79 80 .49 .39 .651
D9S1826 160.2 .82 82 .51 .35 .364
D9S158 163 .72 82 .54 1.49 .071
10:
D10S249 0 .82 82 .49 .21 .583
D10S552 13 .76 83 .55 1.50 .069
D10S189 17.3 .72 83 .55 1.62 .055
D10S570 32.1 .73 83 .49 .39 .651
D10S1653 38.8 .75 83 .48 .61 .730
D10S548 43.4 .59 82 .48 .90 .814
D10S197 50.5 .72 83 .51 .32 .376
D10S208 60.2 .79 83 .52 .57 .286
D10S196 72.5 .70 80 .44 2.39 .990
D10S1652 83.3 .70 79 .53 1.19 .119
D10S537 93.8 .82 82 .51 .38 .352
D10S1686 109.2 .66 82 .45 1.75 .958
D10S185 123.3 .78 83 .52 .66 .256
D10S192 131.2 .84 82 .49 .29 .612
D10S1269 140.2 .64 81 .50 .04 .515
D10S1693 146.1 .82 77 .44 1.96 .973
D10S587 156.6 .82 83 .45 1.52 .934
D10S217 167.2 .82 81 .49 .25 .600
D10S1651 178.3 .64 80 .47 .99 .838
D10S1711 180.5 .61 80 .46 1.47 .928
11:
D11S4046 3.9 .85 83 .51 .50 .310
D11S1338 14.9 .62 83 .53 1.21 .114
D11S902 24.7 .84 80 .54 1.14 .129
D11S904 37 .71 83 .50 .10 .460
D11S935 49.6 .72 82 .50 .14 .555
D11S905 55.7 .81 83 .47 1.01 .843
D11S4191 63.4 .88 83 .54 1.22 .113
D11S987 67.5 .84 83 .55 1.75 .042*
D11S1314 77.5 .79 82 .54 1.30 .099
D11S937 84.6 .76 83 .53 1.20 .118
D11S901 89.8 .68 83 .51 .30 .381
D11S4175 96.3 .84 82 .50 .05 .518
D11S1339 104.8 .70 82 .52 .61 .272
D11S4111 112.9 .80 82 .49 .16 .564
D11S925 123.5 .81 83 .54 1.11 .136
D11S4151 132.9 .61 80 .54 1.58 .060
D11S910 145.6 .72 82 .55 2.02 .023*
D11S4125 152.8 .74 81 .51 .44 .332
12:
D12S352 0 .68 83 .46 1.74 .957
D12S99 13.9 .81 82 .46 1.36 .911
(continued)
Table 2 (Continued)
Chromosome and Marker
Distance
(cM) Heterozygosity No. of Pairs IBD t P
D12S336 21 .74 83 .50 .09 .535
D12S364 31.7 .81 82 .46 1.45 .924
D12S310 36.1 .64 80 .52 .87 .193
D12S1617 45.1 .84 83 .48 .62 .731
D12S345 54.4 .84 83 .49 .30 .619
D12S85 62.7 .80 82 .45 1.41 .919
D12S368 67.3 .66 82 .49 .56 .713
D12S83 76.5 .81 83 .51 .48 .316
D12S326 87.6 .61 80 .47 1.08 .859
D12S351 97.1 .74 83 .53 .92 .181
D12S346 106.1 .73 81 .48 .60 .726
D12S78 113.3 .79 81 .53 .92 .180
D12S79 126.1 .80 82 .49 .20 .581
D12S86 135.1 .68 83 .50 .05 .480
D12S32 4 148.3 .64 83 .47 1.16 .876
D12S36v7 160.9 .71 82 .49 .39 .649
D12S1723 165.7 .79 83 .50 .04 .515
13:
D13S175 7.4 .67 83 .49 .24 .594
D13S217 19.1 .67 82 .52 .75 .229
D13S171 27.3 .65 82 .51 .25 .401
D13S218 35.3 .60 82 .49 .28 .611
D13S263 40.4 .81 82 .52 .64 .262
D13S153 47.5 .89 83 .56 1.84 .034*
D13S156 57.3 .82 83 .54 1.4 .083
D13S170 65.4 .83 82 .54 1.21 .114
D13S265 70.6 .66 83 .53 1.09 .138
D13S159 81.5 .73 82 .50 .06 .524
D13S158 86.9 .73 83 .51 .41 .342
D13S173 95.9 .63 83 .53 .89 .188
D13S1265 101.7 .83 82 .51 .27 .396
D13S285 112.8 .85 78 .51 .38 .353
14:
D14S261 0 .59 82 .51 .22 .413
D14S283 7.5 .8 83 .52 .83 .203
D14S275 21.9 .6 83 .51 .52 .303
D14S70 32.9 .67 83 .45 1.77 .960
D14S288 39.1 .87 83 .53 .90 .187
D14S276 47 .77 83 .54 1.35 .090
D14S63 59 .76 83 .53 1.01 .158
D14S258 65.8 .64 83 .55 1.86 .034*
D14S74 76.4 .8 83 .58 2.82 .003**
D14S68 86.3 .83 83 .52 .55 .292
D14S280 95.5 .68 83 .48 .58 .719
D14S65 108.1 .71 83 .52 .65 .258
D14S985 117.1 .72 83 .53 1.20 .117
D14S292 124.2 .71 83 .51 .33 .371
15:
D15S128 6.1 .85 82 .50 .14 .556
D15S1002 14.5 .76 83 .50 .07 .528
D15S1048 19.1 .66 81 .50 .11 .543
D15S1007 25.9 .82 83 .52 .48 .317
D15S1042 32.3 .78 81 .49 .25 .599
D15S994 40 .76 83 .49 .21 .582
D15S978 45.5 .74 81 .50 .10 .540
D15S117 50.8 .74 82 .50 .01 .503
D15S153 62.1 .79 83 .51 .38 .352
D15S131 70.7 .75 82 .49 .37 .645
D15S205 77.4 .88 83 .53 .96 .171
D15S127 84.8 .83 81 .47 1.06 .853
D15S1004 95.7 .62 81 .48 .93 .822
D15S120 109.6 .79 83 .47 .97 .832
16:
D16S423 8.4 .85 75 .51 .22 .413
D16S404 16.7 .69 82 .51 .30 .383
D16S3075 21.8 .8 81 .49 .17 .566
D16S3017 31.1 .73 79 .47 .94 .824
D16S3046 39.3 .65 83 .47 1.30 .902
D16S3068 46.6 .73 83 .54 1.36 .089
D16S3136 60 .65 82 .48 .70 .758
D16S415 65.6 .69 81 .48 .61 .727
D16S503 81.8 .66 76 .51 .37 .355
D16S515 90.2 .87 77 .48 .59 .723
D16S516 98.3 .72 75 .48 .61 .729
D16S3091 109.1 .83 83 .50 .02 .491
D16S520 123.3 .8 80 .52 .68 .248
17:
D17S849 .6 .74 83 .48 .70 .758
D17S831 6.6 .85 78 .48 .57 .714
D17S938 14.8 .82 81 .48 .76 .774
D17S1852 23.2 .8 83 .49 .25 .598
D17S947 32.8 .85 80 .46 1.23 .888
D17S921 37.3 .73 80 .53 1.11 .135
D17S925 49.5 .71 80 .55 1.96 .027*
D17S1872 58.3 .90 79 .47 .89 .811
D17S1868 65.1 .78 76 .52 .56 .290
(continued)
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Table 2 (Continued)
Chromosome and Marker
Distance
(cM) Heterozygosity No. of Pairs IBD t P
D17S787 75.7 .83 83 .46 1.25 .892
D17S948 84.1 .70 80 .48 .62 .732
D17S949 94.9 .80 82 .51 .40 .344
D17S785 104.7 .70 83 .47 .98 .836
D17S784 117.7 .60 83 .51 .41 .340
D17S928 128.7 .83 82 .52 .46 .325
18:
D18S59 .1 .80 76 .55 1.68 .049*
D18S63 7.9 .71 80 .47 1.25 .892
D18S452 17.7 .81 82 .50 .04 .485
D18S1153 34.7 .81 83 .50 .14 .554
D18S53 40.4 .82 78 .48 .68 .751
D18S478 52.3 .65 83 .50 .14 .554
D18S1102 61.7 .68 82 .44 2.29 .988
D18S474 71.3 .72 76 .49 .39 .651
D18S64 83 .82 83 .50 .06 .476
D18S68 94.4 .72 78 .50 .16 .563
D18S61 102.8 .82 82 .54 1.45 .076
D18S1161 112 .74 82 .54 1.41 .082
D18S462 118 .72 81 .50 .02 .494
D18S70 123.8 .75 82 .50 .07 .528
19:
D19S209 10.8 .82 83 .48 .56 .712
D19S894 15.4 .81 74 .49 .26 .603
D19S884 26 .84 83 .47 1.13 .868
D19S221 35.5 .81 81 .45 1.69 .952
D19S226 41.7 .86 82 .45 1.42 .920
D19S414 53.2 .60 79 .47 1.19 .882
D19S220 61.4 .87 80 .49 .35 .637
D19S420 66 .79 82 .51 .21 .419
D19S902 76.2 .79 83 .51 .33 .370
D19S921 91.7 .84 75 .52 .50 .309
D19S418 97.5 .65 83 .49 .4 .655
D19S210 104.9 .67 83 .51 .30 .382
20:
D20S117 2.9 .82 83 .52 .50 .310
D20S889 11 .78 83 .50 .13 .447
D20S192 18.5 .76 81 .46 1.24 .891
D20S186 33.2 .88 83 .48 .42 .661
D20S112 39.3 .73 83 .51 .26 .399
D20S195 50.2 .74 81 .52 .92 .180
D20S107 54.9 .71 82 .48 .69 .755
D20S119 61 .79 83 .47 .97 .833
D20S178 65.5 .77 82 .48 .69 .755
D20S196 74.5 .81 83 .45 1.69 .953
D20S100 83.4 .71 83 .47 1.28 .899
D20S171 94.4 .71 82 .47 .98 .836
D20S173 96.5 .61 83 .53 1.11 .136
21:
D21S1256 8.6 .82 83 .48 .45 .671
D21S1914 23 .81 83 .48 .50 .690
D21S263 31.4 .82 81 .54 1.14 .129
D21S1252 38.7 .82 83 .52 .70 .243
D21S266 49.9 .82 82 .49 .38 .649
22:
D22S420 0 .70 82 .47 1.19 .881
D22S446 9 .65 82 .46 1.55 .938
D22S315 16.2 .80 83 .46 1.21 .884
D22S280 25.9 .79 83 .49 .42 .662
D22S283 33.4 .75 82 .51 .50 .308
D22S423 40.2 .83 82 .49 .20 .581
D22S274 45.5 .84 79 .51 .29 .386
* .P ! .05
** .P ! .01
imaging (fig. 1a), cerebral angiography (fig. 1b), and
three-dimensional CT angiography (fig. 1c) of a typical
patient with IA who has a saccular aneurysm in the left
middle cerebral artery.
Genomewide Linkage Studies
The sample for linkage study comprised 85 Japanese
nuclear families, and the maximum number of ASPs with
IA was 104 (table 1). Because the quantity of DNA avail-
able from 25 participants was insufficient for genotyp-
ing of the 404 microsatellite markers for genomewide
scan, 154 of the 179 individuals comprised by the 83
ASPs were genotyped. The statistical probability of link-
age between each marker and IA was tested by SIBPAL
(table 2). Regions of the genome were considered to have
suggestive evidence of linkage in the first data set either
if an individual marker attained statistical significance
or if two or more adjacent markers each attainedP ! .01
statistical significance at . By these criteria, sug-P ! .05
gestive evidence of linkage to IA obtains for markers
within three distinct chromosomes: chromosome 5 (mark-
ers D5S428 and D5S644), chromosome 7 (markers
Figure 2 Results of multipoint linkage analyses for high-resolution mapping on chromosomes 5 (a), 7 (b), and 14 (c) in 104 Japanese
sib pairs with IA. Positions of the MLS are indicated by arrows: MLS p 2.24, 3.22, and 2.31, and distances from the p-terminal end (pter)
were 141.4, 86.5, and 73.3 cM, on chromosome 5, 7, and 14, respectively. The borders (defined by LOD 11.0) of positive linkage lie between
markers D5S471 and D5S2010, D7S2415 and D7S657, and D14S258 and D14S74. Additional markers used for high-resolution mapping are
indicated by asterisks (*).
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Figure 3 Physical map of ELN locus. a, Contigs and microsatellite-marker locations at locus. The thicker lines denote clones, which have
been registered in the GenBank database, in the ELN locus; and the numbers in parentheses are the length (in kb) of the clones. The vertical
arrows above the thinner lines indicate positions of eight microsatellite markers at the locus; and distances from ELN are in parentheses.
Blackened rectangles indicate positions of known genes lying near ELN: TBL2p transducin b-like 2; LIMK1p LIM domain kinase 1; RFC2
p replication factor C 2; CYLN2 p cytoplasmic linker 2. b, Expanded view of 43-kb segment of ELN. The exon-intron organization of ELN
and the positions of 14 distinct SNPs are indicated. Nine SNPs, indicated by asterisks (*), were used for pairwise haplotype-association study.
D7S669 and D7S630), and chromosome 14 (markers
D14S258 and D14S74) (table 2). These chromosomes
were further tested by multipoint linkage analysis using
GENEHUNTER. Multipoint analyses of the three regions
showed at least nominal evidence for linkage (defined by
MLS 11.0; data not shown). Linkage analysis of chro-
mosome X by GENEHUNTER indicated no evidence of
linkage (data not shown).
Next, all individuals in the 104 ASPs were genotyped
by addition of microsatellite markers covering the
candidate regions, on chromosomes 5q, 7q, and 14q,
that showed putatively positive evidence of linkage;
10 markers on chromosome 5 (D5S1969, D5S1988,
D5S2103, D5S495, D5S2117, D5S1983, D5S658,
D5S2010, D5S2013, and D5S673), 14 markers on
chromosome 7 (D7S2497, D7S485, D7S691, D7S2427,
D7S2422, D7S499, D7S2415, D7S2472, D7S2421,
D7S2443, D7S2410, D7S479, D7S2504, andD7S2459),
and 9 markers on chromosome 14 (D14S75, D14S989,
D14S980, D14S1011, D14S77, D14S1025, D14S1036,
D14S1037, and D14S1044) were added, for high-res-
olution mapping (see The Whitehead Institute for Bio-
medical Research/MIT Center for Genome Research
web site). Multipoint linkage analyses by GENEHUNT-
ER revealed evidence of linkage to loci on chromosomes
5q22-31 (MLS 2.24, ), 7q11 (MLS 3.22,Pp .00149
), and 14q22 (MLS 2.31, ) (fig.Pp .00046 Pp .00120
2); the MLSs were near markers D5S1983, D7S2472,
and D14S1036, respectively. 1-LOD support intervals
lay between D5S471 and D5S2010, between D7S2415
and D7S657, and between D14S258 and D14S74, com-
prising regions of ∼14, ∼21, and ∼11 cM, respectively.
Physical Map of the ELN Locus
In the search for candidate genes in the linkage regions,
the candidate gene ELN was found, 400 kb from marker
D7S2472 on chromosome 7. Elastin is the predominant
protein of mature elastic fibers in arterial walls. The ELN
locus on 7q11.23 has been extensively analyzed in studies
of WBS (Peoples et al. 2000) and supravalvular aortic
stenosis (Curran et al. 1993; Li et al. 1997; Tassabehji et
al. 1997). A physical map of the ELN locus was recon-
structed on the basis of the GenBank database and a
physical map of microdeletion in WBS (Peoples et al.
2000). A clone (accession number AC005056) contained
the full length of ELN, and the contig was extended to
marker D7S2472, telomeric to ELN. Another clone (ac-
cession number AC005089) was closest to ELN on the
centromeric side; the sequences between ELN and the
latter clone have not been registered in the GenBank da-
tabase. Eight polymorphic dinucleotide or tetranucleo-
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Table 3
Linkage Analysis and Association Study Using Microsatellite Markers at the ELN Locus
MICROSATELLITE MARKER HETEROZYGOSITY DISTANCE FROM ELN
LINKAGE ANALYSIS ASSOCIATION STUDY
IBD t P
No. of Alleles
(CTR/IA)a x2 (df) P
D7S2476 .42 400–500 kb (centromere) .5367 2.021 .0232* 384/328 13.52 (12) .3327
ELN-CEN1 .12 400–500 kb (centromere) .5018 .138 .4453 382/322 4.79 (3) .1881
ELN-M2 .78 Intron 1 (ELN) .5413 1.499 .0687 378/320 19.22 (8) .0137*
ELN-M1 .59 Intron 18 (ELN) .5051 .228 .4100 384/328 3.43 (5) .6338
ELN-TEL1 .87 40 kb (telomere) .5647 2.061 .0212* 382/322 20.78 (14) .1075
ELN-TEL2 .76 60 kb (telomere) .5302 1.209 .1150 382/326 9.20 (10) .5132
ELN-TEL6 .77 300 kb (telomere) .5363 1.264 .1049 374/320 8.39 (9) .4952
D7S2472 .74 400 kb (telomere) .6084 4.426 .000029** 374/328 8.80 (10) .5511
a CTR p controls; IA p patients with IA.
* .P ! .05
** .P ! .01
tide repeats identified in the ELN locus were distributed
as follows: D7S2476 and ELN-CEN1, both at 400–500
kb from ELN, ELN-M2 at intron 1 of ELN (Urban et
al. 1997), ELN-M1 at intron 18 of ELN (Foster et al.
1993), ELN-TEL1 at 40 kb, ELN-TEL2 at 60 kb, ELN-
TEL6 at 300 kb, and D7S2472 at 400 kb, respectively
(fig. 3). All eight markers were tested for linkage, by SIB-
PAL. Although evidence of linkage was not strong, all the
markers showed means 1.5, for alleles sharing linkage,
throughout the region (table 3). The allelic frequencies of
the eight markers were compared in patients with IA ver-
sus controls. A weak allelic association was detected in
the allele-frequency distribution of the marker ELN-M2
( , , ) (table 3). Considered2x p 19.22 dfp 8 Pp .0137
together, these findings indicate that ELN is a primary
candidate gene for IA.
SNPs in ELN
ELN was extensively screened for SNPs. Systemat-
ic direct sequencing was performed on all 34 exons; ac-
ceptor, donor, and branch-point sequences of all introns;
1.0 kb of the putative promoter sequence (Kahari et al.
1990); and 1.2 kb of 3′UTR sequence. Fourteen distinct
SNPs, including two previously published polymorphisms
(Tromp et al. 1991; Urban et al. 1999), were identified
(fig. 3 and table 4). Three of the SNPs occur in the coding
regions: EX5, a CrT substitution at exon 5 (16), and
EX20, a GrA substitution at exon 20 (114), resulted
in amino acid substitutions A71V and G422S, respec-
tively, whereas EX22, a GrA substitution at exon 22
(23), was a silent substitution. Allelic frequencies of the
14 SNPs were compared in patients versus controls (table
4). Allelic-frequency differences between cases and con-
trols were found for two SNPs; but they did not reach
statistical significance ( , , and2x p 3.39 dfp 1 Pp
, for INT20; and , , and2.067 x p 2.97 dfp 1 Pp
, for 3UTR1) (table 4). All of the SNP frequencies of.085
controls were in Hardy-Weinberg equilibrium.
Pairwise Haplotype Association Study of IA
Thirty-six pairwise haplotype combinations were con-
structed from nine SNPs (i.e., PM1, PM2, INT4, EX20,
INT20, INT23, INT32, 3UTR1, and 3UTR2; table 4)
that showed relatively high allelic frequencies (.05).
The pairwise haplotype frequencies were calculated by
a maximum-likelihood estimation using theARLEQUIN
program, and the haplotype frequencies were compared
in the 172 patients with IA versus the 192 controls (fig.
4); most often, two SNPs of any combination created
four haplotypes, reflecting weak LD throughout the
gene. The haplotype frequencies of all pairwise combi-
nations then were compared in a global test with 3 df.
The best evidence of haplotype association was observed
for INT20/INT23 ( , ,2x p 27.90 dfp 3 Pp 3.81 #
). An Mm haplotype (major allele [i.e., M] for610
INT20 and minor allele [i.e., m] for INT23) was more
prevalent in patients with IA than in controls ( 2x p
, , ), with an odds ratio of 1.8511.17 dfp 1 Pp .0008
(95%CI 1.53–2.65). Subjects who were homozygous for
the Mm haplotype and whose haplotype was unambig-
uously determined appeared more frequently among pa-
tients with IA than among controls (10.7% vs. 2.7%;
, , ), with an odds ratio of2x p 9.52 dfp 1 Pp .002
4.39 (95%CI 2.62–12.11). Significant associations also
were detected in the haplotype-frequency distribution of
two combinations: PM2/INT23 ( , ,2x p 14.85 dfp 3
), and INT4/INT23 ( ,3 2Pp 1.94 # 10 x p 24.10
, ) (fig. 4).4dfp 3 Pp 2.39 # 10
Pairwise LD of ELN
The extent of pairwise LD in the 36 pairs of combi-
nations was investigated in complete detail, by two LD
measures—D′ and r2—in 192 controls. LD is generally a
measure of distance between SNPs. However, inELN, the
distribution of LD is highly irregular, and generally weak
degrees were observed between the SNPs (fig. 5a). Among
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Table 4
Polymorphisms in ELN, and Association Study of Patients with IA and of Controls
SNP NAME LOCATION (POSITION a)
CHANGE ALLELE FREQUENCYb
x2 d PMrmc Amino Acid Controls Patients with IA
PM 1 Promoter (1042) CrT .202 (77/382) .208 (69/332) .043 .836
PM 2 Promoter (972) GrA .178 (68/382) .145 (48/332) 1.459 .227
PM 3 Promoter (38) CrT .021 (4/188) .040 (7/174) 1.102 .294
INT 4 Intron 4 (71) GrA .201 (76/378) .178 (60/338) .643 .423
EX 5 Exon 5 (16) CrT AlarVal .021 (4/188) .029 (5/174) .207 .649
INT14 Intron 14 (28) GrA .016 (3/186) .035 (6/170) 1.324 .250
EX 20 Exon 20 (114) GrA GlyrSer .189 (71/376) .210 (71/338) .503 .478
INT 20 Intron 20 (17) TrC .269 (101/376) .210 (71/338) 3.388 .067
EX 22 Exon 22 (23) GrA LeurLeu .011 (4/376) .018 (6/326) .750 .387
INT 23 Intron 23 (24) TrC .294 (113/384) .308 (106/344) .166 .684
INT 26 Intron 26 (20) CrT .016 (3/192) .006 (1/174) .824 .364
INT 32 Intron 32 (34) CrT .052 (20/384) .056 (19/340) .051 .821
3UTR 1 3′UTR (502) A insertion .102 (39/382) .144 (49/340) 2.968 .085
3UTR 2 3′UTR (659) GrC .050 (19/382) .060 (20/336) .153 .696
a No. of nucleotides from nearest start of promoter, intron, exon, or 3′UTR.
b CTR p controls; IA p patients with IA.
c M p major, common allele; m p minor, less common allele.
d df p 1.
these, LD was conserved at PM1/EX20, PM2/INT4,
PM2/INT20, INT4/INT20, INT32/3UTR1, INT32/
3UTR2, and 3UTR1/3UTR2 ( and ). A very′ 2D 1 .7 r 1 .3
weak LD was indicated between INT23 and other SNPs.
A similar LD was observed for patients with IA. Accord-
ing to the extent of LD, the five putative ancestral hap-
lotype groups could be classified: H0p no polymorphism
in the allele; H1p polymorphisms at PM1 and EX20;
H2p polymorphisms at PM2, INT4, and INT20; H3p
polymorphism at INT23; and H4 p polymorphisms at
INT32, 3UTR1, and 3UTR2 (fig. 5b). Because Mm hap-
lotypes at PM2/INT23, INT4/INT23, and INT20/INT23
were significantly more frequent in patients with IA than
in controls (fig. 4), it may well be that the ancestral H3
haplotype puts an individual at risk for IA. A recombinant
haplotype of either H2 and H3 or INT20 and INT23 was
more common in controls than in patients with IA.
Discussion
In the present study, we have identified, by genomewide
linkage study and the candidate-gene approach, a molec-
ular determinant of IA, a determinant that suggests both
the pathogenesis of the disease and also novel therapeutic
targets. Evidence of linkage throughout the genome in 83
Japanese ASPs was established first by SIBPAL analysis,
in which excess allele sharing was found. Evidence of
linkage was observed at markers on chromosomes 5q, 7q,
and 14q. Dense mapping with all 104 ASPs was per-
formed in these regions by multipoint analysis with
GENEHUNTER. The best evidence of linkage was ob-
served on chromosome 7q11, near marker D7S2472. In
the three chromosomal regions, the candidate genes for
either vascular components or vascular formation are
those for lysyl oxidase (LOX), fibrillin 2 (FBN2), and
fibroblast growth factor 1 (FGF1), all on chromosome 5;
ELN and the genes for KREV interaction trapped 1
(KIRT1) and collagen type 1 a2 (COL1A2), all on chro-
mosome 7; and that for latent transforming growth factor
b–binding protein 2 (LTBP2), on chromosome 14.
Defects relating to the medial muscle layer at the
branch points of intracranial major arteries, favorable
sites for IA, are observed frequently, and external elastic
lamina is absent in cerebral arteries. Internal elastic lam-
ina is the major structural support in the cerebral vessels
(Glynn 1940). It is interesting to note that the several
genes associated with elastic-fiber production—that is,
LOX, FBN2, and ELN—lie within the linkage regions.
Pathology examination of IA often reveals a defect in the
internal elastic lamina of IA lesions (Carmichael 1945,
1950; Stebens 1963). Animal models of IA have been
established by treatment with either elastase (Anidjar et
al. 1990; Miskolczi et al. 1998) or b-aminopropionitrile,
which inhibit cross-linking reactions between elastin mol-
ecules (Hashimoto et al. 1978). Defects in or degenera-
tion of the internal elastic lamina, therefore, might play
an important role in the etiology of IA.
In this study, ELN was extensively screened for the
presence of molecular variants, since (a) it gene lies very
close to the marker—D7S2472—that showed the best
evidence for linkage and (b) elastin constitutes the pre-
dominant protein in elastic fibers. We identified 14 SNPs
in ELN, and the allelic frequencies in patients with IA
were compared with those in controls. Although there
appeared to be no allelic association with any SNP, in-
creasing the sample size led to statistical significance, at
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Figure 5 Pairwise LD between SNPs in ELN. a, Extent of pair-
wise LD of ELN, measured by two distinct formulas. The upper and
lower numerals in each box indicate coefficient D′ and r2, respectively.
Formulas for D′ and r2 are described in the text. Pairwise combinations
with relatively high LD measures (defined by and ) in′ 2D 1 .7 r 1 .3
192 controls are indicated, by boxes containing an asterisk (*). b,
Illustration of five ancestral haplotype groups. Black dots represent
the SNPs at each site. H0 p no polymorphism in the allele; H1 p
polymorphisms at PM1 and EX20; H2 p polymorphisms at PM2,
INT4, and INT20; H3 p one polymorphism, at INT23; H4p poly-
morphisms at INT32, 3UTR1, and 3UTR2.
the intron 20 polymorphism. Pairwise haplotype anal-
ysis was performed with combinations of nine SNPs (fig.
4). Haplotype analysis can reveal the degree of predis-
position of a specific allele to a disease and is especially
useful when causal variants have not been identified.
The Mm haplotype at INT20/INT23 was observed
more frequently in patients with IA than in controls and
indicates risk for IA among Japanese ( ,2x p 27.90
, ) (fig. 4). The functional role6dfp 3 Pp 3.81 # 10
of the ELN haplotype in pathophysiology is not known.
Similarly, a recent report has shown that a specific hap-
lotype combination of calpain-10 is a risk factor for
type II diabetes in a Mexican American population
(Horikawa et al. 2000). That study suggests that het-
erozygosity for two different, common haplotypes may
be necessary for the development of diabetes. Analyses
of all the possible pairwise LD revealed weak LD
throughout ELN, and the pairwise LD between INT23
and others in the vicinity was especially weak (fig. 5).
ELN is highly rich in Alu repeats, with possibly 30
Alu sequences within the 43-kb region (data not
shown). Alu repeats may be associated with genome
instability (Calabretta et al. 1982), which could partly
explain the low LD observed in ELN. Indeed, loss of
the exons in primates may be due to an Alu-mediated
recombination event that might confer an evolutionary
advantage in elastic tissue (Szabo et al. 1999). It is cu-
rious that poor LD was found between INT20 and
INT23, whereas a strong association was observed in
the haplotype created by the two SNPs. In general, with
phase-unknown samples, the haplotype may not be pre-
cisely defined at low LD; however, individuals who were
homozygous for the Mm haplotype and whose haplo-
type was unambiguously determined were remarkably
more common among the patients with IA patients than
among controls (10.7% vs. 2.7%; , ,2x p 9.52 dfp 1
), with an odds ratio of 4.39. The Mm hap-Pp .002
lotype, therefore, is associated with IA, and a disease-
causing variant should lie either on the allele within
ELN or, possibly, in a nearby gene.
We have mapped three chromosomal loci for IA and
have identified a candidate gene, ELN, on the basis of
its chromosomal position and function. We have deter-
mined that the Mm haplotype at INT20/INT23 indi-
cates risk for the disease in the Japanese. Long-term
investigation including replication studies in distinct
ethnic groups, as well as functional studies using bio-
chemical and cellular biological techniques, will be nec-
essary to clarify the mechanism of the relationship be-
tween the genetic variation and the disease.
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